Danaher Diagnostics — Goodwill increased by 0.2% to $6.98B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 3.4%, from $6.76B to $6.98B. Over 4 years (FY 2021 to FY 2025), Diagnostics — Goodwill shows relatively stable performance with a -0.3% CAGR.
High goodwill levels indicate a history of M&A; significant changes may signal successful integration or potential future impairment risks.
The premium paid over the fair value of net assets during the acquisition of businesses within the diagnostics segment....
Common for companies that utilize M&A as a core growth strategy.
dhr_segment_diagnostics_goodwill| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $7.03B | $6.97B | $7.04B | $7.01B | $6.84B | $6.71B | $6.88B | $6.88B | $6.87B | $6.81B | $6.91B | $6.84B | $6.84B | $6.93B | $6.76B | $6.84B | $6.97B | $6.97B | $6.98B |
| QoQ Change | — | -0.8% | +1.0% | -0.5% | -2.4% | -2.0% | +2.5% | +0.1% | -0.2% | -1.0% | +1.5% | -1.0% | -0.1% | +1.4% | -2.6% | +1.2% | +2.0% | -0.1% | +0.2% |
| YoY Change | — | — | — | — | -2.7% | -3.9% | -2.4% | -1.8% | +0.4% | +1.5% | +0.5% | -0.6% | -0.5% | +1.9% | -2.2% | -0.1% | +2.0% | +0.5% | +3.4% |
We use cookies for analytics. See our Privacy and Cookie Policy.